Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0J1R.L Stock Summary
Top 10 Correlated ETFs
0J1R.L
In the News
0J1R.L Financial details
Company Rating
Neutral
Market Cap
85B
Income
5.24B
Revenue
64.97B
Book val./share
-6.68
Cash/share
3.85
Dividend
2.4
Dividend %
0.86%
Employees
220K
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
13.49
Forward P/E
-
PEG
-187.32
P/S
1.52
P/B
-31.12
P/C
77.18
P/FCF
21.97
Quick Ratio
0.82
Current Ratio
1.15
Debt / Equity
-22.22
LT Debt / Equity
34.55
-
-
EPS (TTM)
19.3
EPS next Y
-
EPS next Q
-
EPS this Y
-1.03%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
13.38%
Revenue last 5Y
4.82%
Revenue Q/Q
6.72%
EPS Q/Q
52.01%
-
-
-
-
SMA20
-1.5%
SMA50
6.63%
SMA100
33.44%
Inst Own
-
Inst Trans
-
ROA
10%
ROE
-228%
ROC
0.22%
Gross Margin
39%
Oper. Margin
15%
Profit Margin
9%
Payout
11%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
216.0-328.8022
52W High
-9.41%
52W Low
+37.56%
RSI
25.87
Rel Volume
0.99
Avg Volume
1.01K
Volume
995
Perf Week
-9.23%
Perf Month
-6.01%
Perf Quarter
22.47%
Perf Half Y
21.32%
-
-
-
-
Beta
1.672
-
-
Volatility
10.1%, 7.05%
Prev Close
-4.49%
Price
297.13
Change
-5.84%
0J1R.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 150.45 | 152.34 | 181.72 | 207.45 | 238.5 | |
Net income per share | 10.27 | 11.1 | 21.51 | 19.44 | 19.24 | |
Operating cash flow per share | 22.28 | 27.29 | 27.71 | 29.35 | 34.62 | |
Free cash flow per share | 10.09 | 18.91 | 16.65 | 14.21 | 17.21 | |
Cash per share | 2.25 | 5.64 | 4.81 | 3.44 | 3.75 | |
Book value per share | -8.23 | 1.69 | -2.89 | -9.53 | -6.51 | |
Tangible book value per share | -25.89 | -16.81 | -53.16 | -65.51 | -31.37 | |
Share holders equity per share | -8.23 | 1.69 | -2.89 | -9.53 | -6.51 | |
Interest debt per share | 103.87 | 95.93 | 111.11 | 136.42 | 151.81 | |
Market cap | 50.29B | 55.96B | 83.34B | 70.19B | 73.71B | |
Enterprise value | 85.24B | 87.22B | 118.62B | 109.48B | 114.63B | |
P/E ratio | 14.35 | 14.91 | 11.98 | 12.44 | 14.06 | |
Price to sales ratio | 0.98 | 1.09 | 1.42 | 1.17 | 1.13 | |
POCF ratio | 6.62 | 6.06 | 9.3 | 8.24 | 7.82 | |
PFCF ratio | 14.6 | 8.75 | 15.49 | 17.01 | 15.73 | |
P/B Ratio | -17.91 | 97.83 | -89.33 | -25.37 | -41.55 | |
PTB ratio | -17.91 | 97.83 | -89.33 | -25.37 | -41.55 | |
EV to sales | 1.66 | 1.69 | 2.02 | 1.82 | 1.76 | |
Enterprise value over EBITDA | 8.69 | 8.74 | 9.47 | 9.11 | 9.02 | |
EV to operating cash flow | 11.21 | 9.45 | 13.24 | 12.85 | 12.15 | |
EV to free cash flow | 24.75 | 13.63 | 22.04 | 26.53 | 24.46 | |
Earnings yield | 0.07 | 0.07 | 0.08 | 0.08 | 0.07 | |
Free cash flow yield | 0.07 | 0.11 | 0.06 | 0.06 | 0.06 | |
Debt to equity | -11.97 | 54 | -36.86 | -13.69 | -22.22 | |
Debt to assets | 0.75 | 0.65 | 0.68 | 0.72 | 0.7 | |
Net debt to EBITDA | 3.56 | 3.13 | 2.82 | 3.27 | 3.22 | |
Current ratio | 1.44 | 1.42 | 1.41 | 1.38 | 1.18 | |
Interest coverage | 3.92 | 4.66 | 6.33 | 5.21 | 4.97 | |
Income quality | 2.17 | 2.46 | 1.29 | 1.51 | 1.8 | |
Dividend Yield | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.16 | 0.04 | 0.09 | 0.12 | 0.13 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.18 | 0.18 | 0.19 | 0.18 | 0.17 | |
Capex to operating cash flow | -0.55 | -0.31 | -0.4 | -0.52 | -0.5 | |
Capex to revenue | -0.08 | -0.06 | -0.06 | -0.07 | -0.07 | |
Capex to depreciation | -1.6 | -1.04 | -1.25 | -1.48 | -1.54 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | -0.1 | |
Graham number | 43.61 | 20.55 | 37.38 | 64.56 | 53.1 | |
ROIC | 0.17 | 0.17 | 0.21 | 0.19 | 0.19 | |
Return on tangible assets | 0.1 | 0.1 | 0.17 | 0.13 | 0.11 | |
Graham Net | -112.51 | -107.55 | -125.66 | -150.85 | -167.56 | |
Working capital | 3.44B | 3.63B | 3.96B | 3.74B | 2.27B | |
Tangible asset value | -8.83B | -5.69B | -8.05B | -9.73B | -8.55B | |
Net current asset value | -34.43B | -32.27B | -35.71B | -38.87B | -40.22B | |
Invested capital | -11.97 | 54 | -36.86 | -13.69 | -22.22 | |
Average receivables | 7.09B | 7.22B | 7.58B | 8.5B | 9.43B | |
Average payables | 2.74B | 3.22B | 3.82B | 4.18B | 4.24B | |
Average inventory | 1.79B | 1.94B | 2.01B | 2.03B | 2.04B | |
Days sales outstanding | 52.54 | 50 | 50.36 | 53.95 | 55.99 | |
Days payables outstanding | 24.31 | 29.14 | 30.58 | 30.23 | 27.92 | |
Days of inventory on hand | 15.47 | 16.7 | 14.77 | 14.75 | 13.33 | |
Receivables turnover | 6.95 | 7.3 | 7.25 | 6.77 | 6.52 | |
Payables turnover | 15.02 | 12.52 | 11.94 | 12.07 | 13.07 | |
Inventory turnover | 23.59 | 21.86 | 24.71 | 24.75 | 27.38 | |
ROE | -1.25 | 6.56 | -7.46 | -2.04 | -2.95 | |
Capex per share | -12.19 | -8.38 | -11.06 | -15.14 | -17.42 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 55.87 | 56.3 | 57.78 | 59.79 | 65.16 | |
Net income per share | 7.5 | 4.92 | 4.35 | 3.98 | 6.05 | |
Operating cash flow per share | 9.11 | 6.51 | 9.02 | 9.14 | 10.07 | |
Free cash flow per share | 4.34 | 2.19 | 4.5 | 4.91 | 5.71 | |
Cash per share | 3.61 | 3.39 | 3.5 | 3.67 | 3.85 | |
Book value per share | -9.98 | -9.01 | -8.39 | -9.13 | -6.68 | |
Tangible book value per share | -68.57 | -33.79 | -33.44 | -34.74 | -32.18 | |
Share holders equity per share | -9.98 | -9.01 | -8.39 | -9.13 | -6.68 | |
Interest debt per share | 138.17 | 142.05 | 143.6 | 146.88 | 150.28 | |
Market cap | 67.06B | 72.3B | 83.31B | 66.57B | 71.85B | |
Enterprise value | 106.35B | 112.03B | 123.19B | 106.8B | 112.77B | |
P/E ratio | 8.06 | 13.26 | 17.46 | 15.42 | 11.18 | |
Price to sales ratio | 4.33 | 4.64 | 5.25 | 4.11 | 4.15 | |
POCF ratio | 26.54 | 40.1 | 33.66 | 26.85 | 26.87 | |
PFCF ratio | 55.69 | 119.31 | 67.51 | 49.98 | 47.43 | |
P/B Ratio | -24.23 | -28.98 | -36.18 | -26.87 | -40.5 | |
PTB ratio | -24.23 | -28.98 | -36.18 | -26.87 | -40.5 | |
EV to sales | 6.86 | 7.19 | 7.77 | 6.59 | 6.52 | |
Enterprise value over EBITDA | 33.62 | 35.12 | 40.22 | 37.33 | 31.41 | |
EV to operating cash flow | 42.08 | 62.14 | 49.77 | 43.08 | 42.17 | |
EV to free cash flow | 88.33 | 184.87 | 99.83 | 80.18 | 74.44 | |
Earnings yield | 0.03 | 0.02 | 0.01 | 0.02 | 0.02 | |
Free cash flow yield | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | |
Debt to equity | -13.69 | -15.57 | -16.9 | -15.88 | -22.22 | |
Debt to assets | 0.72 | 0.74 | 0.73 | 0.72 | 0.7 | |
Net debt to EBITDA | 12.42 | 12.45 | 13.02 | 14.06 | 11.4 | |
Current ratio | 1.38 | 1.23 | 1.2 | 1.15 | 1.18 | |
Interest coverage | 5.3 | 5.08 | 4.74 | 4.33 | 5.7 | |
Income quality | 1.21 | 1.32 | 2.07 | 2.3 | 1.66 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.07 | 0.13 | 0.14 | 0.15 | 0.1 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.18 | 0.18 | 0.18 | 0.18 | 0.17 | |
Capex to operating cash flow | -0.52 | -0.66 | -0.5 | -0.46 | -0.43 | |
Capex to revenue | -0.09 | -0.08 | -0.08 | -0.07 | -0.07 | |
Capex to depreciation | -1.76 | -1.58 | -1.63 | -1.49 | -1.47 | |
Stock based compensation to revenue | 0.01 | 0 | 0 | 0 | -0.1 | |
Graham number | 41.04 | 31.59 | 28.64 | 28.6 | 30.16 | |
ROIC | 0.05 | 0.05 | 0.05 | 0.04 | 0.06 | |
Return on tangible assets | 0.05 | 0.03 | 0.03 | 0.02 | 0.03 | |
Graham Net | -157.91 | -158.92 | -162.53 | -167.19 | -171.89 | |
Working capital | 3.74B | 2.51B | 2.34B | 1.89B | 2.27B | |
Tangible asset value | -9.73B | -9.36B | -9.18B | -9.42B | -8.55B | |
Net current asset value | -38.87B | -38.94B | -39.25B | -39.94B | -40.22B | |
Invested capital | -13.69 | -15.57 | -16.9 | -15.88 | -22.22 | |
Average receivables | 8.73B | 8.78B | 8.69B | 8.95B | 9.57B | |
Average payables | 4.2B | 4B | 3.8B | 3.98B | 4.19B | |
Average inventory | 2.04B | 2.08B | 2.07B | 2.04B | 2.03B | |
Days sales outstanding | 51.7 | 49.97 | 49.44 | 50.97 | 51.84 | |
Days payables outstanding | 29.16 | 25.78 | 25.37 | 26.38 | 26.27 | |
Days of inventory on hand | 14.23 | 14.26 | 13.61 | 12.94 | 12.54 | |
Receivables turnover | 1.74 | 1.8 | 1.82 | 1.77 | 1.74 | |
Payables turnover | 3.09 | 3.49 | 3.55 | 3.41 | 3.43 | |
Inventory turnover | 6.33 | 6.31 | 6.62 | 6.96 | 7.18 | |
ROE | -0.75 | -0.55 | -0.52 | -0.44 | -0.91 | |
Capex per share | -4.77 | -4.32 | -4.52 | -4.23 | -4.36 |
0J1R.L Frequently Asked Questions
What is HCA Healthcare, Inc. stock symbol ?
HCA Healthcare, Inc. is a US stock , located in Nashville of Tn and trading under the symbol 0J1R.L
What is HCA Healthcare, Inc. stock quote today ?
HCA Healthcare, Inc. stock price is $297.13 today.
Is HCA Healthcare, Inc. stock public?
Yes, HCA Healthcare, Inc. is a publicly traded company.